PROCF — Sofgen Pharma SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $58.18m
- $340.12m
- $373.80m
Brief: Procaps Group Receives Additional Delinquency Letter
Brief: Procaps Group Announces Key Shareholder And Board Decisions, Committee Restructuring, And Leadership Updates
Brief: Procaps Issues Shareholder Letter Update
Brief: Procaps Issues Shareholder Letter Update
Brief: Hoche Partners Pharma Holding Says On Aug 19, Filed Petition With Court Against Procaps Group
Brief: Procaps Group Delays Filing Of Annual Report On Form 20-F
Brief: LatAm Healthcare Firm Procaps Exploring Strategic Alternatives
Brief: Procaps Q3 Revenue USD 118 Million
Brief: Procaps Group And Genomma Lab Announce Agreement To Manufacture And Market Softgel Products In Latin America
Brief: Procaps Group Appoints Jose Antonio Vieira as CEO Starting 2024
Brief: Procaps Group Reports Second Quarter 2023 Results
Brief: Procaps Q2 Revenue USD 110 Million
Brief: Procaps Group Reports First Quarter 2023 Results
Brief: Procaps Group Reports Fourth Quarter And Full Year 2022 Results
Brief: Procaps Group Announces Termination Of Acquisition Agreement With Grupo Somar
Brief: Procaps Group provides update On Proposed Acquisition Of Grupo Somar
Brief: Procaps Group To Acquire Grupo Somar (Including Química Y Farmacia, Gelcaps And Related Entities) From Advent International, Gaining An Important Presence In Mexico, The Region's Second Largest Market
Brief: Procaps Group Announces Capacity Expansion Plans In The United States With Construction Of New Gummy Manufacturing Facility In Florida
Brief: Procaps Group Acquires 1St U.S.-Based Softgel Production Facility